The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2014.996016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

Oncotarget
Oncology
2016English

Erratum To: Targeting the PELP1-KDM1 Axis as a Potential Therapeutic Strategy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy